ATR and cancer: Promotion of S-phase entry by induced overexpression of cyclin E1, a feature found frequently in cancer cells (particularly ovarian cancer) was also demonstrated to confer sensitivity to the ATR inhibitor ETP46464, and ETP46464 was also more cytotoxic in tumours derived from Ras and Myc transformed MEF cells [118].